Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines

1 Jan 2012

Abstract excerpt

Previous studies have demonstrated that pluripotency-associated transcription factors, such as Oct3/4, Nanog and Sox2, play a crucial role in the development and malignant progression of various types of tumors. Breast cancer is the most frequent cancer among females, being a heterogeneous disease, with distinct morphologies, metastatic behavior and therapeutic responses. The expression of Oct3/4, Nanog and Sox2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Pluripotent Stem Cells Research
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23197999
DOI: 10.3892/ol.2012.916

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell linesPMID 23197999Read ↗

The role of Nanog expression in tamoxifen-resistant breast cancer cellsSemantic proximity Read ↗

Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.Semantic proximity Read ↗

Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary GlandSemantic proximity Read ↗

Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patientsSemantic proximity Read ↗

Pluripotency transcription factors and cancer stem cells: small genes make a big differenceSemantic proximity Read ↗

Distinctive expression pattern of OCT4 variants in different types of breast cancerSemantic proximity Read ↗

Differential expression of Oct3/4 in human breast cancer and normal tissuesSemantic proximity Read ↗

Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.Semantic proximity Read ↗

Malignant potential of breast cancer stem cells is associated with environment- dependent upregulation of the Oct3/4 networkSemantic proximity Read ↗

Pluripotency Genes and Their Functions in the Normal and Aberrant Breast and BrainSemantic proximity Read ↗

Cancer Stem Cells Stemness Transcription Factors Expression Correlates with Breast Cancer Disease StageSemantic proximity Read ↗

Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.